Lyubov Slashcheva, Rick Rader, MD, and Stephen B. Sulkes, MD
Designation of people with intellectual and developmental disabilities as a medically underserved population would not solve problems of access to care.
AMA J Ethics. 2016;18(4):422-429. doi:
10.1001/journalofethics.2016.18.4.pfor1-1604.
Sriya Bhattacharyya, PhD, Aaron S. Breslow, PhD, Jianee Carrasco, and Benjamin Cook, PhD, MPH
Force is codified in law, so force utilization inequity demands that we consider connections between systemic oppression and individuals’ responses in clinical settings.
AMA J Ethics. 2021;23(4):E340-348. doi:
10.1001/amajethics.2021.340.
Annette Hanson, MD, Ron Pies, MD, and Mark Komrad, MD
Authors respond to “How Should Physicians Care for Dying Patients with Amyotrophic Lateral Sclerosis?” by arguing that patients’ motives for accessing death with dignity laws should be thoroughly explored and that temporarily limiting patient autonomy can promote well-being at the end of life.
AMA J Ethics. 2018;20(11):E1107-1109. doi:
10.1001/amajethics.2018.1107.
Alexander Craig, MPhil and Elizabeth Dzeng, MD, PhD, MPH
Responding to “Added Points of Concern about Caring for Dying Patients,” authors argue that physicians’ refusal to prescribe lethal drugs in accordance with states’ death with dignity laws could damage patient-physician relationships and harm patients.
AMA J Ethics. 2018;20(11):E1110-1112. doi:
10.1001/amajethics.2018.1110.
Trafficking-specific ICD-10-CM codes account for physical, social, and psychological dimensions of trafficked patients’ experiences. Data collected by clinicians can also motivate improvements in health policy, resource allocation, and prevention.
AMA J Ethics. 2018;20(12):E1143-1151. doi:
10.1001/amajethics.2018.1143.
Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful.
AMA J Ethics. 2020;22(8):E723-728. doi:
10.1001/amajethics.2020.723.
Kristen N. Pallok and David A. Ansell’s “Should Clinicians Be Activists?” highlights how physician activists risk retaliation from “economically and socially” privileged physician leaders and organizational leadership who “have been trained to comply” with structural inequity.
AMA J Ethics. 2022;24(7):E694-696. doi:
10.1001/amajethics.2022.694.